Publicaciones en las que colabora con José Antonio Lepe (9)

2023

  1. In Vitro and In Vivo Virulence Study of Listeria monocytogenes Isolated from the Andalusian Outbreak in 2019

    Tropical Medicine and Infectious Disease, Vol. 8, Núm. 1

  2. Role of blaTEM and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection

    Journal of Infection, Vol. 87, Núm. 3, pp. 220-229

2021

  1. Semirapid detection of piperacillin/tazobactam resistance and extended-spectrum resistance to b-lactams/b-lactamase inhibitors in clinical isolates of escherichia coli

    Microbiology Spectrum, Vol. 9, Núm. 2

2020

  1. Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 77-85

  2. In vitro effect of ceftazidime-avibactam pressure on ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae clinical isolates

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 9

2019

  1. Phylogeny, resistome, and virulome of escherichia coli causing biliary tract infections

    Journal of Clinical Medicine, Vol. 8, Núm. 12

2018

  1. Heteroresistance to piperacillin-tazobactam in clinical isolates of Escherichia coli sequence type 131

    Antimicrobial Agents and Chemotherapy

2017

  1. Comparison of the in vitro activity of ampicillin and moxifloxacin against listeria monocytogenes at achievable concentrations in the central nervous system

    Journal of Medical Microbiology, Vol. 66, Núm. 6, pp. 713-720

2014

  1. In vitro and intracellular activities of fosfomycin against clinical strains of Listeria monocytogenes

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 2, pp. 135-139